Rapid plaque clearance with anti-amyloid therapy for Alzheimer's disease: in consideration of donanemab treatment duration from real-world cases.
Jeongyeon Hwang, Alison Pietras, Georges Naasan et al.Neurocase
Esplora gli studi internazionali, consulta le fonti originali e approfondisci la ricerca con sintesi in italiano.
La ricerca AI avanzata è inclusa nei piani Plus e Professionista. La consultazione della biblioteca è aperta a tutti.
Accedi Scopri i pianiJeongyeon Hwang, Alison Pietras, Georges Naasan et al.Neurocase
Angela Mailis, Seng Bin Ang, Tania Di Renna et al.Climacteric : the journal of the International Menopause Society
Lidia M V R MouraNeurology. Clinical practice
Ricardo Engel, Emily Landon, Elizabeth Bell et al.Injury
Tammie L S Benzinger, Petrice M Cogswell, Arvin Arani et al.The Lancet. Neurology
Christiane Montag, Anna-Lena Bröcker, Samuel Bayer et al.The lancet. Psychiatry
Jennifer Dunne, Mario Siervo, Kaarin J Anstey et al.The Lancet. Public health
James White, Sarah J Hampton, Shaun GreeneEmergency medicine Australasia : EMA
Adam de Havenon, Kevin N Sheth, Carolyn A Fredericks et al.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Multiple-etiology dementia (MED), typically characterized by coexisting vascular and neurodegenerative pathology, is the most common cause of late-life cognitive impairment. Autopsy and biomarker studies demonstrate frequent overlap between cerebral small vessel disease, stroke-related injury, amyloid-β deposition, and tau pathology, yet therapeutic development has…
Debarati Rakshit, Mohit Nema, Awanish MishraBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Alexis N Bosseler, Erica Peterson, Katherine K Meltzoff et al.Developmental cognitive neuroscience
Yifei Zhang, Yajun Kong, Shuanbao ZhaoOncology letters
Shahin Yaghoobi, Fatemeh Salboukh, Donald Llyod-Jones et al.Stroke
Robin M Murray, Dominic Oliver, Aikaterini Dima et al.World psychiatry : official journal of the World Psychiatric Association (WPA)
Mohammed A Abdel-RasolInflammopharmacology
Neuroinflammation is a central driver of neurodegeneration in Alzheimer's disease (AD) and Parkinson's disease (PD), driven by interconnected pathways involving microglial state dysregulation, inflammasome activation, cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling, impaired mitophagy, CD33-TREM2 imbalance, gut-brain axis disruption, and peripheral immune…
Anna Banaszkiewicz, Katarzyna Chyl-Tanaś, Hanna Górecka et al.Developmental cognitive neuroscience
Haoxiang Chen, Sha Zhao, Jie Yu et al.Journal of neural engineering
Alyssa R Mickle, Jesús D Peñaloza-Aponte, Caitlin Brennan et al.Journal of neurophysiology
Yoshihiro NodaExpert review of medical devices
Nitin Kumar, Izhar Khan, Jyoti Singh et al.Bioorganic chemistry